BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes
This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.Vancouver,...
Pharmaceutical
Defence Successfully Completes the First Milestone of Its Collaboration Agreement with Orano
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
Biophytis and SEQENS Sign a Partnership to Produce Sarconeos (BIO101) Active Compound
PARIS, FRANCE / ACCESSWIRE / July 18, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology...
Pressure BioSciences Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering
During Interview with "Cannabis Talks" (Cannabis and Hemp Insider), CEO Ric Schumacher Reveals Transition into Aggressive Growth Phase for Revolutionary...
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
Advancing Next-Generation Wearable Patient Engagement and Diagnostic Technology Designed to Enable More Efficient Detection of Eye DiseasesALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos...
Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership
DENVER, CO / ACCESSWIRE / July 17, 2023 / Laxxon Medical, a leading 3D screen printing pharma-technology company, announced today...
Elektrofi Appoints Victoria Sluzky as Chief Technology Officer to Drive Innovation and Technical Excellence
BOSTON, July 17, 2023 (GLOBE NEWSWIRE) -- Today Elektrofi, a biopharmaceutical formulation technology company focused on leveraging strategic partnerships to...
Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma
With a standard review, FDA set a PDUFA target action date of May 16, 2024FORT LEE, N.J., July 17, 2023...
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology...
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023
Figure 1 Acumen Pharmaceuticals, Inc. Figure 2 Acumen Pharmaceuticals, Inc.Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating...
Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement
VANCOUVER, British Columbia, July 14, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or...
BridgeBio to Host Investor Call to Share Topline 30-month Results from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy on July 17, 2023
PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused...
Intellipharmaceutics Announces Second Quarter 2023 Results
TORONTO, ON / ACCESSWIRE / July 14, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...
POP Biotechnologies and EuBiologics’ EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial
BUFFALO, NY / ACCESSWIRE / July 14, 2023 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top...
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission
Company targeting FDA submission in the first half of 2024AVERSA™ Fentanyl is the flagship product of the Company's AVERSA™ PlatformORLANDO,...
ReCor Responds to European Society of Hypertension’s (ESH) Updated Guidelines for Management of Arterial Hypertension
Treating hypertension is complex, and European guidelines reinforce the safety and effectiveness of renal denervation as a treatment option to...
CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition
BELLEVUE, Wash.--(BUSINESS WIRE)--#CurvaFix--CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of...
CureVac Announces Update to the Management Team
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 14, 2023 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
In line with the Company’s Fix, Fund, Propel approach, Dana J Moss, JD joins Navidea’s Board, adding depth in legal...
Model N Announces Date of Third Quarter Fiscal Year 2023 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance, plans to announce financial results...